Chair Rodgers Applauds VA Coverage of Alzheimer’s Drug, Urges CMS to Reconsider

Mar 14, 2023
Press Release

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) released the following statement regarding today’s announcement of a Veterans Health Administration policy to cover a key treatment for Alzheimer's Disease that has been approved by the U.S. Food and Drug Administration (FDA): 

“It’s welcome news that the VA will cover a new Alzheimer’s treatment for many veterans, which will give hope to those battling the disease as well as their families and caregivers. The Centers for Medicare and Medicaid Services should follow suit by reconsidering its coverage policy for Medicare patients, which has created a one-size-fits-all coverage restriction for an entire class of FDA-approved treatments. Seniors shouldn’t be prohibited from receiving the same treatment that patients in the VA system can receive under the supervision of their doctors simply because they’re on Medicare.” 

READ: Rodgers, Smith: Biden Admin Doubles Down on Restricting Medicare Coverage for Seniors